A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2024-03-13
Summary
A prospective cohort study of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome patients who have presented with their acute episode and are in remission within the last 30 days. They will be followed for 12 months from the time of their initial scan, followed by a long-term follow up study.
Conditions
- Thrombotic Thrombocytopenic Purpura
Interventions
- DIAGNOSTIC_TEST
-
CT Perfusion Study
Brain and cardiac CT perfusion scan
- DIAGNOSTIC_TEST
-
Echocardiogram
Speckle tracking Echocardiography
- DIAGNOSTIC_TEST
-
neuro-cognitive assessment
Cambridge Brain Sciences neuro-cognitive assessment
- DIAGNOSTIC_TEST
-
MRI
MRI to assess white matter changes
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Huang · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-01-01
Countries
- Canada
Study Locations
More Related Trials
-
Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura
NCT05046717 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura
NCT07310342 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Italian iTTP Registry
NCT06376786 ·Status: RECRUITING
-
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
NCT00907751 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED
-
Research of Predictive Factors to Immune Thrombopenic Purpura
NCT01648556 ·Status: COMPLETED ·Phase: NA
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00908037 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
NCT04323748 ·Status: RECRUITING ·Phase: PHASE1
-
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
NCT03465020 ·Status: UNKNOWN
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Eltrombopag Phase III Study In Chinese Chronic ITP Patients
NCT01762761 ·Status: COMPLETED ·Phase: PHASE3
-
Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
NCT06979765 ·Status: RECRUITING ·Phase: NA
-
Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
NCT06945861 ·Status: RECRUITING
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
NCT03939637 ·Status: COMPLETED ·Phase: PHASE3
-
Association of Platelet Parameters With Bleeding Severity in Children With ITP
NCT03810352 ·Status: COMPLETED
-
Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)
NCT01443351 ·Status: WITHDRAWN
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2